What's driving Biosimilars Market ; Eminent Players - Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences
Biosimilars Market size is set to exceed USD 69 billion by 2025; according to a new research study published by Global Market Insights, Inc. Cost effectiveness of biosimilars will be a major market boosting factor as it will lead to growing demand and adoption rate of the same. Biosimilars are usually less expensive as compared to other reference products such as biologics and bio betters. Implementation of safe and cost-effective biosimilars in the U.S. will further lead to health improvements and reducing the health expenditure. Hence, low cost of drugs as compared to other drugs will increase the demand and adoption of biosimilars, thereby augmenting the business growth in near future.Biosimilars market is estimated to grow due to high number of patent expirations of biologics drugs, government cost saving initiatives and increase in prevalence of chronic diseases. Several well known biologics are estimated to loose their patents in the forthcoming years, giving the chance for other big pharma players to manufacture their biosimilars, thus, set to increase in number of biosimilar applications and approvals, and augmenting the industry growth.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3328
However, presence of biologics and bio betters will be one the major market impeding factors. Presence of sophisticated biologic drugs still in the market along with several bio betters and generic versions of the drugs will hamper the business growth over the estimation period.
Recombinant glycosylated proteins market is estimated to grow at around 28.7% over the estimation period. Increase in number of people suffering from chronic disorders such as cancer and blood disorders will result in growing demand for biosimilars. Also, recent launch of molecular antibody biosimilars in developed regions of North America and Europe will boost the growth of recombinant glycosylated proteins over the forthcoming years.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3328
Application of biosimilars in autoimmune diseases was valued at USD 1,387.9 million in the year 2018. Increase in prevalence of autoimmune disease such as arthritis, inflammatory bowel disease and psoriasis will be major market impact rendering factor. As per the National Institutes of Health, around 23 million people suffer from autoimmune diseases. Hence, growing number of people with autoimmune disease and need for cost-effective medication for the disease treatment will result in augmenting the business growth.
In-house manufacturing of biosimilars was valued at USD 7,843.5 million in the year 2018. Presence of state-of-art facilities in the company along with better monitoring of the product manufacturing will lead to growing in-house manufacturing of biosimilars. Also, flexibility of operational and financial capabilities of the company will further augment market growth in the near future.
Development of biosimilars using recombinant DNA technology is estimated to grow at around 26.2% over the projection period. Several of the biosimilars products are developed using rDNA technology that enhances the product quality and efficiency of the product.
U.S. biosimilars market is estimated to grow at significant rate of 38.1% over the projection period. Presence of several big pharma players and recent regulatory approvals of biosimilar products in the country will augment the business growth. Also, several biosimilar products in line for product approval will result in boosting the sales in the forthcoming years. China dominated the Asia Pacific biosimilars market and was valued at USD 1,498.1 million in the year 2018. Presence of several biosimilar products manufacturing companies in the country along with over 100 biosimilars in development will boost the business growth.
Biosimilars market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
Biosimilars Market by Product
• Recombinant Non-Glycosylated Proteins
o Human Growth Hormone
o Granulocyte Colony-Stimulating Factor (Filgrastim)
o Insulin
o Interferon
Alfa
Beta
• Recombinant Glycosylated Proteins
o Erythropoietin
Alfa
Zeta
o Monoclonal Antibodies
Infliximab
Rituximab
Adalimumab
Trastuzumab
Bevacizumab
Etanercept
o Follitropin
Alpha
Beta
o Low Molecular Weight Heparin
Biosimilars Market by Application
• Hematology
o Neutropenia
o Anemia
o Others
• Oncology
o Lung Cancer
o Brain Cancer
o Breast Cancer
o Cervical Cancer
o Colorectal Cancer
o Leukemia
Non-Hodgkin Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Others
o Others
• Autoimmune Disease
o Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Juvenile Arthritis
Ankylosing Spondylitis
Others
o Inflammatory Bowel Disease (IBD)
Ulcerative Colitis
Crohn's Disease
Others
o Psoriasis
o Others
• Growth Hormone Deficiency
• Diabetes
• Others
Biosimilars Market by Manufacturer
• Contract Research and Manufacturing Services
• In-house
Biosimilars Market by Technology
• Recombinant DNA Technology (rDNA technology)
• Monoclonal Antibodies (MAb) Technology
The above information is provided for the following regions/countries:
• North America
o U.S.
o Canada
• Europe
o Germany
o UK
o France
o Spain
o Italy
o Russia
o Turkey
o Austria
o Belgium
o Bulgaria
o Czech Republic
o Denmark
o Finland
o Greece
o Hungary
o Ireland
o Netherlands
o Norway
o Romania
o Slovakia
o Slovenia
o Sweden
o Switzerland
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
• Rest of the world
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving Biosimilars Market ; Eminent Players - Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences here
News-ID: 1766854 • Views: …
More Releases from Global Market Insights, Inc.
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products.
Prenatal vitamin ingredients can…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…